Europe HPV Testing And Pap Test Market By Application (Pap Test (Vaginal Cancer, Cervical Cancer)), By Test Type (HPV Testing (Co-Testing, Follow-Up, Primary))
- Advertising -
Europe HPV Testing and Pap Test Market size was around USD 860 million in 2016. It is expected to grow at a CAGR of 6.1% to reach USD 1.16 billion by 2021.
It captures 25% of the global market.
The Papanicolaou test is a procedure of cervical screening utilized for detecting potentially pre-cancerous and cancerous processes in the cervix (opening of the womb or uterus). Irregular findings are usually followed up by more sensitive diagnostic tests, and based on the need interventions that prevent progression to cervical cancer are implemented.
- Advertising -
View Full Report: www.marketdataforecast.com/market-…test-market-3775/
Numerous factors for example, growing aging population, rising number of cervical cancer cases, growing awareness of cervical cancer screening programs, and government initiative and funding are driving the growth of the HPV testing market. Moreover, in order to carry out awareness campaigns, the government and major companies are funding the universities for developing enhanced technologies to facilitate effective screening, to mitigate the incidence of late-stage cervical cancer.
Request for Sample Brochure: www.marketdataforecast.com/market-…75/request-sample
In spite of that, changes in regulatory guidelines for cervical cancer screening and HPV vaccination are few factors hindering the growth of this market. Additionally, the uncertain reimbursement scenario is a major challenge inhibiting the growth of the HPV test and Pap test market.
- Market Segmentation
- HPV Testing
- Follow-Up HPV Testing
- Primary HPV Testing
- PAP Test
- Y-o-Y Growth Analysis, By Type
- Market Attractiveness Analysis, By Type
- Market Share Analysis, By Type
- Cervical Cancer Screening
- Vaginal Cancer Screening
- Y-o-Y Growth Analysis, By Application
- Market Attractiveness Analysis, By Application
- Market Share Analysis, By Application
- End User
- Physicians’ Offices and Clinics
- Y-o-Y Growth Analysis, By End User
- Market Attractiveness Analysis, By End User
- Market Share Analysis, By End User
HPV testing market is segmented into two major segments on the basis of test type, namely, HPV testing. Follow-up HPV testing, HPV primary testing and co-testing are three sub-categories of HPV testing.
The Pap test category is estimated to command the largest share of the HPV testing market in 2016. HPV testing category is projected to grow at the highest CAGR in the forecast period because of the growing incidences of cervical cancer, rising awareness of HPV screening, along with the introduction of HPV primary test.
If we go by application, the Europe HPV testing market is segmented into two major categories, namely, vaginal cancer screening and cervical cancer screening.
Inquire Report: www.marketdataforecast.com/market-…rket-3775/inquire
The cervical cancer screening application category is estimated to command the largest share of the Pap test market in 2016. This large share is because of the rising incidences of cervical cancer and government initiatives to increase the awareness regarding the benefits of cervical cancer screening.
Pap test market is categorized into three segments on basis of end users, namely, laboratories, hospitals, physicians’ offices and clinics. The laboratories end-user category is likely to command the largest share of the Pap test market in 2016.
Moreover, the hospitals end-user category is estimated to grow at the highest CAGR in the future, because most of the diagnostic tests are carried out in-house in hospitals using advanced technologies in relatively shorter period of time.
On the basis of geography the Europe market is segmented into UK, Spain, Germany, France and others. It is the second largest market in terms of market share.
UK is the leading market in this region.
Abbott Laboratories (U.S.), Qiagen N.V. (The Netherlands), Hologic Inc. (U.S.), Roche Diagnostics (Switzerland), Quest Diagnostics (U.S.), Becton, Dickinson and Company (U.S.) are the key players operating in the HPV testing market.
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information: